CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation

Código QR

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation

The pathological accumulation of <inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">α</mi></semantics></math></inline-formula>-Synuclein (<inline-fo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lea Elsholz, Yasmine Wasser, Patrick Ziegler, Pardes Habib, Aaron Voigt
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	CK1BP CK1 α-Synuclein α-Synuclein oligomerization α-Synuclein aggregation Parkinson’s disease Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/4167b442f4db4701b03eff41f93c238e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor
por: Mohammadi S, et al.
Publicado: (2017)

α-synuclein interaction with zero-valent iron nanoparticles accelerates structural rearrangement into amyloid-susceptible structure with increased cytotoxic tendency
por: Tahaei Gilan SS, et al.
Publicado: (2019)

Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
por: Karen M. Delgado-Minjares, et al.
Publicado: (2021)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2
por: Kazunori Sano, et al.
Publicado: (2021)

(De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants
por: Joana Angélica Loureiro, et al.
Publicado: (2021)

Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
por: Ruichen Su, et al.
Publicado: (2021)

Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
por: Jennifer A. Macdonald, et al.
Publicado: (2021)

Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
por: Charlotte F. Brzozowski, et al.
Publicado: (2021)

Graphene-Based Nanoparticles as Potential Treatment Options for Parkinson’s Disease: A Molecular Dynamics Study
por: Alimohammadi E, et al.
Publicado: (2020)

Commentary: Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit
por: Jiahui Zhang, et al.
Publicado: (2021)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Rachel Kelly, et al.
Publicado: (2021)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values
por: Afaf El-Ansary, et al.
Publicado: (2021)

Molecular chaperones and Parkinson's disease
por: Shenglan Hu, et al.
Publicado: (2021)

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease
por: Eva Nordström, et al.
Publicado: (2021)

Assessing Plasma Levels of α-Synuclein and Neurofilament Light Chain by Different Blood Preparation Methods
por: Kuo-Hsuan Chang, et al.
Publicado: (2021)

Effects of the Toxic Metals Arsenite and Cadmium on α-Synuclein Aggregation In Vitro and in Cells
por: Emma Lorentzon, et al.
Publicado: (2021)

COMPARISON EFFECT BETWEEN PEGAGAN (Centella asiatica) EXTRACT AND PRAMIPEXOLE TOWARD LOCOMOTOR ACTIVITIES, α - SYNUCLEIN, AND NRF2 EXPRESSION IN ZEBRAFISH PARKINSON MODEL
por: Ayu Trisnawati, et al.
Publicado: (2019)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu S, et al.
Publicado: (2020)

Sgt1 Regulates α-Synuclein Subcellular Localization and Expression of Parkinson’s Disease Related Genes, <i>PINK1</i> and <i>PARK9</i>
por: Anastasiia Bohush, et al.
Publicado: (2021)

Pure Micropapillary Rectal Carcinoma with CK7 and CK20 Coexpression and Loss of CDX2 Reactivity
por: Lino-Silva,Leonardo Saúl
Publicado: (2012)

Kaempferol Has Potent Protective and Antifibrillogenic Effects for α-Synuclein Neurotoxicity In Vitro
por: Masatoshi Inden, et al.
Publicado: (2021)

Revisit the Cellular Transmission and Emerging Techniques in Understanding the Mechanisms of Proteinopathies
por: Jinwen Jiang, et al.
Publicado: (2021)

Association between Sleep, Alzheimer’s, and Parkinson’s Disease
por: Sumire Matsumoto, et al.
Publicado: (2021)

TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
por: Anastazja M. Gorecki, et al.
Publicado: (2021)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
por: Rongfang Que, et al.
Publicado: (2021)

Missense Mutations Modify the Conformational Ensemble of the α-Synuclein Monomer Which Exhibits a Two-Phase Characteristic
por: Adrien Guzzo, et al.
Publicado: (2021)

Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study
por: Qi Zheng, et al.
Publicado: (2021)

Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration
por: Mantas Ziaunys, et al.
Publicado: (2021)

Neuroprotective Effects and Related Mechanisms of Echinacoside in MPTP-Induced PD Mice
por: Zhang ZN, et al.
Publicado: (2021)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Tian-Sin Fan, et al.
Publicado: (2021)

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
por: Gupta AK, et al.
Publicado: (2019)

The Bacterial Amyloids Phenol Soluble Modulins from <i>Staphylococcus aureus</i> Catalyze Alpha-Synuclein Aggregation
por: Caroline Haikal, et al.
Publicado: (2021)

Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein
por: Judit Oláh, et al.
Publicado: (2021)

Mechanism of Autophagy Regulation in MPTP-Induced PD Mice via the mTOR Signaling Pathway by Echinacoside
por: Zhang ZN, et al.
Publicado: (2021)

SERUM MYELOPEROXIDASE, MALONDIALDEHYDE, ALPHA-SYNUCLEIN LEVELS IN PATIENTS WITH EPILEPSY
por: Fatma Şimşek, et al.
Publicado: (2021)

Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation
por: Stefania Vogiatzis, et al.
Publicado: (2021)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm F, et al.
Publicado: (2016)

Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in <i>Drosophila</i>
por: Jean-Noël Arsac, et al.
Publicado: (2021)